ArticleCancer management and research2026

Ki-67 and Platelet-to-Lymphocyte Ratio (PLR) as Predictors of Progression-Free Survival in Metastatic Breast Cancer Receiving CDK4/6 Inhibitors: Clinical Implications.

Savas Gokcek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.